1. Academic Validation
  2. Mechanisms for cardiac calcium pump activation by its substrate and a synthetic allosteric modulator using fluorescence lifetime imaging

Mechanisms for cardiac calcium pump activation by its substrate and a synthetic allosteric modulator using fluorescence lifetime imaging

  • PNAS Nexus. 2023 Dec 22;3(1):pgad453. doi: 10.1093/pnasnexus/pgad453.
Jaroslava Šeflová 1 Carlos Cruz-Cortés 2 Guadalupe Guerrero-Serna 2 Seth L Robia 1 L Michel Espinoza-Fonseca 2
Affiliations

Affiliations

  • 1 Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL 60153, USA.
  • 2 Center for Arrhythmia Research, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract

The discovery of allosteric modulators is an emerging paradigm in drug discovery, and signal transduction is a subtle and dynamic process that is challenging to characterize. We developed a time-correlated single photon-counting imaging approach to investigate the structural mechanisms for small-molecule activation of the cardiac sarcoplasmic reticulum CA2+-ATPase, a pharmacologically important pump that transports CA2+ at the expense of adenosine triphosphate (ATP) hydrolysis. We first tested whether the dissociation of sarcoplasmic reticulum CA2+-ATPase from its regulatory protein phospholamban is required for small-molecule activation. We found that CDN1163, a validated sarcoplasmic reticulum CA2+-ATPase activator, does not have significant effects on the stability of the sarcoplasmic reticulum CA2+-ATPase-phospholamban complex. Time-correlated single photon-counting imaging experiments using the nonhydrolyzable ATP analog β,γ-Methyleneadenosine 5'-triphosphate (AMP-PCP) showed ATP is an allosteric modulator of sarcoplasmic reticulum CA2+-ATPase, increasing the fraction of catalytically competent structures at physiologically relevant CA2+ concentrations. Unlike ATP, CDN1163 alone has no significant effects on the CA2+-dependent shifts in the structural populations of sarcoplasmic reticulum CA2+-ATPase, and it does not increase the pump's affinity for CA2+ ions. However, we found that CDN1163 enhances the ATP-mediated modulatory effects to increase the population of catalytically competent sarcoplasmic reticulum CA2+-ATPase structures. Importantly, this structural shift occurs within the physiological window of CA2+ concentrations at which sarcoplasmic reticulum CA2+-ATPase operates. We demonstrated that ATP is both a substrate and modulator of sarcoplasmic reticulum CA2+-ATPase and showed that CDN1163 and ATP act synergistically to populate sarcoplasmic reticulum CA2+-ATPase structures that are primed for phosphorylation. This study provides novel insights into the structural mechanisms for sarcoplasmic reticulum CA2+-ATPase activation by its substrate and a synthetic allosteric modulator.

Figures
Products